Core Viewpoint - Tianyi Medical has received EU MDR certification for multiple products, indicating compliance with the latest EU medical device regulations, which enhances its market access and sales potential in Europe [1][3]. Trading Information Summary - On November 5, 2025, Tianyi Medical's stock closed at 58.8 yuan, up by 5.0%, with a turnover rate of 12.94% and a trading volume of 37,500 shares, resulting in a transaction value of 216 million yuan [1]. - The net inflow of main funds was 18.84 million yuan, while speculative funds saw a net inflow of 13.12 million yuan; however, retail investors experienced a net outflow of 31.97 million yuan [1][3]. Company Announcement Summary - Tianyi Medical has obtained EU MDR certification for products including Extracorporeal Blood Tubing Set, Oral/Enteral Syringe, Oral/Enteral Syringe with ENFit connector, and Arterial-Venous Fistula Needle Set, with the latter being a newly certified product [1][3]. - The certification, effective from November 4, 2025, and valid until January 5, 2028, signifies that the company's products meet the latest EU regulatory requirements, facilitating their promotion and sales in overseas markets [1].

Group 1 - Triangle Defense signed a gas turbine project development and framework order agreement with Siemens Energy [1] - The development agreement allows Triangle Defense to qualify for supplying specific items to Siemens Energy, detailing technical prerequisites and standards [1] - Triangle Defense specializes in the research, production, and sales of forged products in aviation, aerospace, and shipping industries [1] Group 2 - Aerospace Hongtu was suspended from military procurement for three years due to alleged violations during a procurement activity [2] - The suspension will last from July 6, 2024, to July 6, 2027, affecting the company's participation in military material procurement [2] - Aerospace Hongtu focuses on satellite operations and data collection [3] Group 3 - Kaili Medical's executives purchased a total of 460,000 shares, investing approximately 13.15 million yuan [4] - The average purchase prices were 28.70 yuan and 28.53 yuan per share [4] - Kaili Medical is engaged in the research, production, and sales of medical diagnostic and treatment equipment [5] Group 4 - Muyuan Foods reported a 22.28% year-on-year decline in sales revenue from live pigs in October, totaling 10.33 billion yuan [6] - The average selling price of live pigs decreased by 32.73% year-on-year to 11.55 yuan per kilogram [6] - Muyuan Foods is involved in pig farming and slaughtering [7] Group 5 - Niuwei Co. plans to acquire 40% of its subsidiary Dongwu Machinery for 139 million yuan, aiming for full ownership [8] - Niuwei Co. specializes in the research, manufacturing, and sales of industrial valves [9] Group 6 - Jinlong Automobile reported a 14.71% year-on-year decline in bus sales in October, with 4,121 units sold [10] - Jinlong Automobile focuses on the production and sales of bus products [10] Group 7 - ST Tianshan reported a 242.54% year-on-year increase in sales revenue from live livestock in October, totaling 13.35 million yuan [11] - The company sold 1,367 head of livestock, marking a significant increase compared to previous periods [11] - ST Tianshan is involved in the breeding and sales of cattle and dairy products [12] Group 8 - Ningbo Port expects a 12.4% year-on-year increase in container throughput in October, reaching 4.56 million TEUs [13] - The total cargo throughput is projected to be 99.6 million tons, a 5.3% increase year-on-year [13] - Ningbo Port engages in port handling and logistics services [13] Group 9 - Amcare Pharma received approval for supplementary drug applications and clinical trials for its products [14] - The company is focused on new drug development and utilizes a MAH model for production [14] Group 10 - Lude Environment plans to change its stock name to "Lude Technology" while keeping its full name and stock code unchanged [15] - The company specializes in waste treatment and resource utilization technologies [15] Group 11 - Hualan Co. plans to increase its stake in the company by investing between 30 million and 60 million yuan [16] - The maximum purchase price is set at 58.08 yuan per share [16] - Hualan Co. focuses on the development and sales of packaging materials for injectable drugs [16] Group 12 - Caina Co. is using 140 million yuan of idle funds to purchase structured deposits from a bank, with expected annual yields between 0.70% and 1.85% [17] - Caina Co. specializes in the research, production, and sales of injection and laboratory consumables [17] Group 13 - Zhenghong Technology reported a 52.80% year-on-year decrease in sales revenue from live pigs in October, totaling 4.32 million yuan [18] - The company sold 400 head of pigs, marking a significant decline compared to previous periods [18] - Zhenghong Technology is involved in feed production and pig farming [18] Group 14 - Caida Securities received approval from the CSRC to issue bonds totaling up to 6 billion yuan [19] - The company is engaged in securities brokerage, investment banking, and asset management [19] Group 15 - Jiayuan Technology signed a copper foil supply framework agreement with CATL, establishing a long-term partnership [20] - The agreement includes collaboration in the supply and production of materials for new battery technologies [20] Group 16 - Haikong Group announced the resignation of its general manager due to personal career planning [21] - The company is involved in automotive passenger transport and related services [21] Group 17 - Beizhi Technology's application to acquire 100% of Suzhou Suike Intelligent Technology has been accepted by the Shanghai Stock Exchange [22] - The company specializes in intelligent logistics systems and equipment [22] Group 18 - Yikang Pharma's subsidiary received approval for clinical trials of a new injection for chronic hepatitis B [23] - The company focuses on the production and sales of raw and formulated pharmaceutical products [23] Group 19 - Hengyuan Coal Power plans to acquire 100% of two coal companies for 440 million yuan [24] - The acquisition includes assuming debts totaling 1.137 billion yuan [24] - Hengyuan Coal Power is involved in coal mining and sales [24] Group 20 - Yangpu Medical announced the cancellation of a production arrangement for a medical device [25] - The company specializes in precision medical and testing services [25] Group 21 - Kailong High-Tech plans to establish a 195 million yuan industry fund focusing on unlisted companies [26] - The company is involved in air pollution control and new energy management systems [26] Group 22 - Yingli Co. received approval for its application to acquire a majority stake in a company [27] - The company specializes in precision electronic components and related manufacturing [27] Group 23 - Tianyi Medical's arterial-venous puncture device received EU MDR certification, valid until January 2028 [28] - The company focuses on medical devices for blood purification and care [28] Group 24 - Chuangyuan Co. appointed a new president, effective until the end of the current board term [29] - The company specializes in the design and production of paper products [29] Group 25 - Shanghai Laishi's new indication for a drug received clinical trial approval [30] - The company focuses on the production and sales of blood products [30] Group 26 - Fengmao Co. plans to issue convertible bonds to raise up to 520 million yuan for expansion and working capital [31] - The company specializes in precision rubber components [31] Group 27 - Yinuo Si's shareholder plans to transfer 3% of the company's shares through an inquiry process [32] - The company provides comprehensive R&D services in the biopharmaceutical sector [32] Group 28 - Phoenix Shipping plans to use up to 50 million yuan of idle funds for cash management [33] - The company is involved in dry bulk shipping and logistics services [33] Group 29 - Xingyuan Zhuomei received a notification to supply magnesium alloy components worth 2.021 billion yuan to a new energy vehicle manufacturer [34] - The project is expected to start mass production in the third quarter of 2026 [34] Group 30 - Landai Technology's subsidiary plans to sell electric drive assembly assets for 110 million yuan [35] - The company specializes in power transmission and display technology [35] Group 31 - Yuexiu Capital plans to distribute a cash dividend of 0.90 yuan per share [36] - The company is involved in asset management and private equity [36] Group 32 - Northeast Securities plans to distribute a cash dividend of 1.00 yuan per share, totaling 234 million yuan [37] - The company focuses on wealth management and investment banking [37] Group 33 - Jinguang Electric won a bid for a project from the State Grid worth 21.7976 million yuan [38] - The company specializes in the research and manufacturing of power distribution equipment [39] Group 34 - Huarong Co. plans to repurchase shares worth between 40 million and 125 million yuan [40] - The company focuses on the production and sales of explosion-proof electrical equipment [40] Group 35 - Baiyang Pharma signed a distribution agreement for a blood product, gaining exclusive rights in specific markets [41] - The company specializes in the development and commercialization of medical innovations [41] Group 36 - Li Qun Co.'s director plans to reduce his stake by up to 71,000 shares due to personal financial needs [42] - The company is involved in retail and logistics services [42] Group 37 - Su Li Co.'s shareholder plans to reduce his stake by up to 0.48% of the company's shares [43] - The company specializes in the production and sales of fine chemical products [43] Group 38 - Shenzhen Ruijie obtained a commitment letter for a stock repurchase loan of up to 15.3 million yuan [44] - The company provides project management and evaluation services [44] Group 39 - Fudan Zhangjiang's shareholder plans to reduce his stake by up to 1% of the company's shares [45] - The company focuses on biopharmaceutical research and development [45] Group 40 - Ningbo Zhongbai's shareholder plans to reduce his stake by up to 1% of the company's shares [46] - The company is involved in retail and wholesale operations [46] Group 41 - Jingyi Co. announced a change in control due to a judicial auction of shares [47] - The company specializes in copper processing and digital carbon services [47] Group 42 - Luoping Zinc Electric's subsidiary obtained a new safety production license for mining operations [48] - The company focuses on hydropower and mining activities [48]

Core Viewpoint - Tianyi Medical (301097.SZ) has received the EU Medical Device Regulation (MDR) certification for several of its products, indicating compliance with the latest EU medical device regulations and enabling continued legal sales in relevant overseas markets [1] Product Certification - The certified products include: - Extracorporeal Blood Tubing Set - Oral/Enteral Syringe - Oral/Enteral Syringe with ENFit connector - Arterial-Venous Fistula Needle Set [1] Market Implications - The acquisition of MDR certification allows the company to meet the latest market entry conditions in the EU, which is expected to enhance the promotion and sales of its products in corresponding markets [1]

Core Viewpoint - Tianyi Medical (301097.SZ) has received the EU Medical Device Regulation (MDR) certification for several of its products, indicating compliance with the latest EU medical device regulations and enabling continued legal sales in relevant overseas markets [1] Product Certification - The certified products include: - Extracorporeal Blood Tubing Set - Oral/Enteral Syringe - Oral/Enteral Syringe with ENFit connector - Arterial-Venous Fistula Needle Set [1] Market Implications - The transition from the previous EU MDD certification to the new MDR certification allows the company to meet the latest market entry requirements in the EU, which is expected to enhance the promotion and sales of its products in the corresponding markets [1]

格隆汇11月5日丨天益医疗(301097.SZ)公布，公司于近日收到欧盟医疗器械法规(Medical Device Regulation (EU) 2017/745，简称"MDR")认证证书。 ...

证书编号：MDR 750054 R000 证券代码： 301097 证券简称：天益医疗 公告编号：2025-056 宁波天益医疗器械股份有限公司 关于公司产品获得欧盟 MDR 认证的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 宁波天益医疗器械股份有限公司（以下简称"公司"）于近日收到欧盟医疗 器械法规（Medical Device Regulation (EU) 2017/745，简称"MDR"）认证证书， 现将有关情况公告如下： 一、MDR 认证证书的具体情况 证书名称：欧盟质量管理体系证书（EU Quality Management System Certificate） 注册号：CN-MF-000029875 认证产品：Extracorporeal Blood Tubing Set（体外循环血路）、Oral/Enteral Syringe（喂食注射器）、Oral/Enteral Syringe with ENFit connector（带 ENFit 接 头的喂食注射器）、Arterial-Venous Fistula Needle Set（动 ...

Core Insights - The medical device sector experienced a rise of 1.13% on October 31, with Caina Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 3954.79, down 0.81%, while the Shenzhen Component Index closed at 13378.21, down 1.14% [1] Medical Device Sector Performance - Caina Co., Ltd. (301122) saw a closing price of 30.38, with a significant increase of 19.98% and a trading volume of 91,000 shares, amounting to a transaction value of 259 million [1] - Spring Medical (688236) closed at 28.88, up 14.47%, with a trading volume of 84,200 shares and a transaction value of 235 million [1] - ZhenDe Medical (603301) closed at 95.00, increasing by 9.07% with a trading volume of 211,900 shares, resulting in a transaction value of 1.951 billion [1] - Other notable performers included TuoJing Life (300642) with an 8.81% increase, and Rejing Bio (688068) with an 8.70% increase [1] Capital Flow Analysis - The medical device sector saw a net inflow of 475 million from institutional investors, while retail investors experienced a net outflow of 108 million [2][3] - Major stocks like Mindray Medical (300760) had a net inflow of 262 million from institutional investors, but a net outflow of 1.27 billion from retail investors [3] - Other stocks such as Furuishi (300049) and Lepu Medical (300003) also showed significant net inflows from institutional investors, indicating strong institutional interest [3]

Market Overview - As of October 27, the Shanghai Composite Index closed at 3996.94 points, with an increase of 1.18% [1] - The Shenzhen Component Index closed at 13489.40 points, up by 1.51% [1] - The ChiNext Index closed at 3234.45 points, rising by 1.98% [1] Trading Activity - A total of 2530 stocks saw an increase in average transaction volume, with 78 stocks experiencing a growth of over 50% [1] - 2034 stocks reported a decrease in average transaction volume [1] - Notable stocks with significant increases in transaction volume include Xinri Co., Haomai Technology, and Changbao Co. [1] Individual Stock Performance - Xinri Co. reported a daily increase of 10.02% with an average transaction volume of 1456 shares, showing a 253.73% increase [1] - Haomai Technology increased by 10.01% with an average transaction volume of 784 shares, reflecting a 206.77% increase [1] - Changbao Co. rose by 9.95% with an average transaction volume of 2716 shares, marking a 197.17% increase [1] - Tianyi Medical saw a significant increase of 20.00% with an average transaction volume of 575 shares, up by 153.85% [1] Active Stocks by Transaction Count - Geer Software had a notable increase in transaction count, rising by 3312.09% with 106,389 transactions [2] - Huajian Group experienced a decrease of 9.99% but had a transaction count increase of 1338.50% with 220,091 transactions [2] - Shanghai Port Bay reported a 1.59% increase with 41,109 transactions, reflecting a 723.50% increase [2] Summary of Notable Stocks - Tianyi Medical, Wanlang Magnetic Plastic, and Jialan Technology all reported significant increases in both transaction volume and count, indicating heightened trading activity [1][2] - Stocks like Xinyuan Co. and Juzhu Co. also showed substantial increases in transaction metrics, suggesting potential investment interest [1][2]

Strong Individual Stocks - As of October 27, the Shanghai Composite Index rose by 1.18% to 3996.94 points, the Shenzhen Component Index increased by 1.51% to 13489.4 points, and the ChiNext Index climbed by 1.98% to 3234.45 points. A total of 64 stocks in the A-share market hit the daily limit up [1] - The top three strong stocks based on consecutive trading days and turnover rate are: - Shilong Industrial (002748) with 5 consecutive limit ups and a turnover rate of 30.47% - Shenkai Co., Ltd. (002278) with 5 limit ups in 6 days and a turnover rate of 57.16% - CITIC Heavy Industries (601608) with 4 limit ups in 6 days and a turnover rate of 9.0% [1] Strong Concept Sectors - The top three concept sectors based on A-share performance are: - Storage Chips with a rise of 3.49% - AI PC with an increase of 3.2% - National Big Fund Holdings with a growth of 3.01% [2][3] - The top ten concept sectors and their respective performance are detailed in the provided table, showcasing various technology and innovation-related sectors [3]

Core Points - Tianyi Medical experienced a trading halt with a daily turnover rate of 23.08% and a transaction volume of 364 million yuan, showing a price fluctuation of 13.78% [2] - The stock was listed on the Shenzhen Stock Exchange due to a closing price increase of 20.00%, with a net selling amount of 24.68 million yuan from brokerage seats [3] - The top five brokerage seats accounted for a total transaction volume of 167 million yuan, with buying transactions amounting to 71.34 million yuan and selling transactions totaling 96.02 million yuan, resulting in a net sell of 24.68 million yuan [3] Trading Data - The largest buying brokerage was Zhongtai Securities with a purchase amount of 17.03 million yuan, while the largest selling brokerage was Zheshang Securities with a selling amount of 32.52 million yuan [3] - The stock saw a net inflow of 14.47 million yuan from main funds, with a significant single net inflow of 16.17 million yuan, while large single funds experienced a net outflow of 1.71 million yuan [3] - Over the past five days, the net inflow of main funds amounted to 10.00 million yuan [3]